<DOC>
	<DOCNO>NCT01960426</DOCNO>
	<brief_summary>Utilization health resource test base strategy versus empiric dose escalation strategy manage Crohn 's disease Ulcerative Colitis subject loss response infliximab adalimumab .</brief_summary>
	<brief_title>Evaluation Health Costs Resource Utilization</brief_title>
	<detailed_description>The purpose study evaluate utilization health resource test base strategy versus empiric dose escalation strategy manage Crohn 's disease Ulcerative Colitis subject loss response infliximab adalimumab .</detailed_description>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Males 18 year age old receive azathioprine 6 mercaptopurine . Nonpregnant , nonlactating female , 18 year age old . Females child bear potential must negative serum pregnancy test prior randomization , must use hormonal ( oral , implantable injectable ) barrier method birth control throughout study . [ define minimum one year since last menstrual period ] ) . Documented diagnosis CD UC . Active disease symptom visit 1 define : a. CD subject : HBS ~ 6 UC subject : PMCS ~ 4 . Current infliximab therapy ( naive adalimumab ) current adalimumab therapy ( naive infliximab ) . A minimum 13 week infliximab adalimumab treatment prior visit 1 follow dose : Stable dose azathioprine , 6 mercaptopurine , methotrexate , and/or 5aminosalicylates 4 week prior visit 1 . Contraindication use either infliximab adalimumab . Current infliximab treatment naive adalimumab Current adalimumab treatment naive infliximab . Infliximab dose prior visit 1 5 mg/kg week 0 , 2 6 q8w . Adalimumab dose prior visit 1 160 mg week 0 , 80 mg week 2 , 40 mg q2w . Received investigational drug within 30 day prior visit 1 . Serious underlying disease CD UC opinion investigator may interfere subject 's ability participate fully study . History alcohol drug abuse opinion investigator may interfere subject 's ability comply study procedure . Stools positive clostridium difficile . Pregnant lactating woman . Change dose azathioprine , 6 mercaptopurine , methotrexate , and/or 5aminosalicylates 4 week prior visit 1 . Males 22 year age less receive azathioprine 6 mercaptopurine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Harvey Bradshaw score</keyword>
	<keyword>Partial Mayo Clinical Score</keyword>
	<keyword>Infliximab</keyword>
	<keyword>Adalimumab</keyword>
</DOC>